Share Twitter LinkedIn Facebook Email Sattva Neelapu, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicines, MD Anderson Cancer Center, discusses Clinical Studies Examining Axicabtagene Ciloleucel. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Cell Therapy for Solid Tumors: Immunotherapy Biomarkers Anusha Kalbasi, MD MOASC [2023] Immunotherapy 2 Mins Read